Cue biopharma, inc. reports earnings results for the third quarter ended september 30, 2019

Cue biopharma, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 7.094 million compared to usd 12.759 million a year ago. net loss was usd 6.990 million compared to usd 12.559 million a year ago. basic loss per share was usd 0.31 compared to usd 0.62 a year ago. for the nine months, operating loss was usd 27.754 million compared to usd 27.730 million a year ago. net loss was usd 27.782 million compared to usd 27.359 million a year ago. basic loss per share was usd 1.3 compared to usd 1.36 a year ago.
CUE Ratings Summary
CUE Quant Ranking